Courtney Andersen studies the role of estrogen receptor-alpha in ovarian cancer.
Chris Barnes investigates the structural details by which transcription factor activity regulates RNA Polymerase II during the universal process of eukaryotic gene expression.
Soma Jobaggy studies nitrated fatty acid pharmacology and the antioxidant response in hypertensive end-organ damage.
Allison Nagle studies growth factor receptor signaling in breast cancer.
DNA Repair



Graduate faculty who study DNA Repair (Click to see their detailed research profile)

Christopher Bakkenist - DNA damage signaling
Kara Bernstein - Repair of DNA damage is crucial to prevent accumulation of mutations that can cause human disease, such as cancer. Our lab studies how double-strand breaks in the DNA, one of the most lethal types of DNA lesions, are repaired. By understanding the mechanism of double-strand break repair and the role of DNA repair proteins in this process, we will uncover mechanisms of tumorigenesis and cancer progression. We will then use this knowledge to aid in diagnosis/prognosis of different types of cancers and to find novel therapeutic targets.
Roderick O'Sullivan - Study of the consequences that defective chromatin assembly and altered epigenetic mechanisms may have in cancer and aging.
Ben Van Houten - Mitochondrial dysfunction in cancer and neurodegenerative diseases , structure function of DNA repair enzymes/proteins.
STUDENT NEWS


UPCOMING EVENTS
2/22/2018 12:00 PM Pharmacology & Chemical Biology Seminar Series
Jonathan Barroso Gonzalez, Ph.D.


2/26/2018 8:30 AM Molecular Pharmacology Journal Club
Stephanie Mutchler


3/1/2018 12:00 PM Pharmacology & Chemical Biology Seminar Series
Carolyn Cummins, Ph.D.


Pharmacology and Chemical Biology Event Calendar

Program Achievements

Molecular Pharmacology Graduate Program Ranked #2 in National Research Council Rankings

Outcomes:  Time to disseration, last five graduating clasess:  4.5 years, Completion Rate: 84.8%

Ranked #12 in National of Institute of Health funding of departments of Pharmacology

Ranked in the top 15 in funding for twenty two consecutive years




Back to Top